ATP Holdings ehf has acquired 6,922,897 shares in Alvotech across two market transactions on December 17 and December 19,...

ATP Holdings ehf. has filed two manager-and-related-party transactions with Luxembourg’s market regulator involving Alvotech: an acquisition of 4,812,257 shares...

Enlivex Therapeutics’ primary digital treasury asset, the Rain token, began trading on KuCoin on January 6, 2026, expanding secondary...

Relation and Deerfield Management have formed a research collaboration that allows Relation to nominate AI- and biology-derived targets for...

The mid-sized oncology biotech firm was blindsided. After three years of aggressive expansion and a pipeline bolstered by the...

Nicox has repaid all secured debt with Kreos Capital and secured up to €4 million in new unsecured bond...

Coherus Oncology has introduced the non-proprietary name tagmokitug for its anti-CCR8 monoclonal antibody and published preclinical and translational clinical...

Soleno Therapeutics has published the pivotal randomized withdrawal data for VYKAT XR (diazoxide choline extended-release) in the Journal of...

Syndax Pharmaceuticals will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, following a year...

Halozyme Therapeutics and Skye Bioscience have signed a non-exclusive global collaboration and license agreement enabling Skye to use Halozyme’s...